Parental Somatic Mosaicism Detected During Prenatal Diagnosis
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Natalie J Chandler und 4 weiteren Autor:innen. Beteiligte Einrichtung: NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Mosaicism, Noninvasive Prenatal Testing, Prenatal Diagnosis, Parents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Biomedical Research Centre at Great Ormond Street Hospital.
Abstract (Originalsprache)
Objective
Accurate recurrence risks are essential for genomic counselling and parental reproductive choices. Historically, Sanger sequencing was used to test parental samples, which has a limited sensitivity of ∼ 10% for detecting somatic mosaicism. Next generation sequencing (NGS) methods, utilised for non‐invasive prenatal diagnosis (NIPD) and trio prenatal exome sequencing in our laboratory, have greater sensitivity. Here we review the cases of parental somatic mosaicism we have detected and discuss its impact on management.
Method
Laboratory databases from 1 January 2015 to 30 September 2022 were reviewed to identify all cases where parental somatic mosaicism was detected during NIPD and prenatal exome testing.
Results
During the development of NIPD testing, we identified 10/131 (7.6%) families with parental somatic mosaicism. In six cases where NGS detected levels between 0.37% and 8.82%, prior testing with Sanger sequencing had not detected mosaicism. In our exome sequencing cohort, we detected parental mosaicism in 4/101 (3.96%) cases. Clinical features of the condition were identified in 2/14 parents.
Conclusion
The sensitivity of the testing technique needs to be considered when counselling parents on recurrence risk. Parents need to be aware that modern approaches to prenatal diagnosis may allow identification of mosaicism, which may have implications for their own health and change recurrence risks for future pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
- Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.
ORCID-Profile: Natalie J Chandler, Elizabeth Scotchman, Lyn S Chitty
Förderung
- NIHR Biomedical Research Centre at Great Ormond Street Hospital
Zitieren
APA
Chandler, N. J., Scotchman, E., McKay, F., Ramachandran, V., & Chitty, L. S. (2025). Parental Somatic Mosaicism Detected During Prenatal Diagnosis. Prenatal Diagnosis. https://doi.org/10.1002/pd.6712
Vancouver
Chandler NJ, Scotchman E, McKay F, Ramachandran V, Chitty LS. Parental Somatic Mosaicism Detected During Prenatal Diagnosis. Prenatal Diagnosis. 2025. doi:10.1002/pd.6712
BibTeX
@article{Chandler2025,
author = {Chandler, Natalie J and Scotchman, Elizabeth and McKay, Fiona and Ramachandran, Vijaya and Chitty, Lyn S},
title = {Parental Somatic Mosaicism Detected During Prenatal Diagnosis},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6712}
}
EUVIMED